Resolve BioSciences GmbH, based in Monheim am Rhein, is registered at the Düsseldorf local court under HRB 88596 as a small corporation. The company develops and aims to commercialize the "genexyz" platform, which the employee incentive program explicitly identifies as an objective for development and commercialization. In fiscal year 2022 the company recorded a net loss of EUR -19,034,659 and continues to incur planned start-up losses driven by research and development costs. On average 56 employees were employed during the year and 2022 financing included a convertible loan agreement of TEUR 8,997.5 and capital increases totaling TEUR 60,000.
Die Organisation und die Umsetzung transformativer Forschungsprojekte für Biowissenschaften und diagnostische Anwendungen für Hochschulen und bioindustrielle Unternehmen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Düsseldorf Local Court, HRB 88596 (as of 29 October 2026)
| Name | Type | City |
|---|---|---|
| Axel Heinemann | Geschäftsführer(in) | Düsseldorf |
Source: German Commercial Register (Handelsregister) Düsseldorf Local Court, HRB 88596 (as of 29 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2022 | €1,344,192 | -€19,033,407 | €55,640,280 | 56 |
| 2021 | €1,821,645 | -€14,287,493 | €7,316,349 | 41 |
| 2020 | ≤ €12M1 | -€3,571,328 | €12,192,442 | 23 |
| 2019 | — | -€163,282 | €3,115,606 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Sign in to download data
Source: German Commercial Register (Handelsregister) Düsseldorf Local Court, HRB 88596 (as of 29 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €5,549,932 | 58.1% |
| Material Costs | €2,490,604 | 26.1% |
| Depreciation | €1,415,482 | 14.8% |
| Interest & Similar | €104,293 | 1.1% |
